Canthaxanthin (CX) as a high‐value carotenoid is widely used in medical, pharmaceutical, cosmetic, chemical, and food industries. In this review, recent developments in the biotechnological production of CX associated with comprehensive insights on CX biosynthesis pathways to improve CX production are critically scrutinized. This article explains the role of carotenogenic genes in the precursor's synthesis of functional CX ingredients. It also explores the possibilities for productivity enhancement of microbial CX in upstream and downstream processes. Moreover, several promising directions for future studies are introduced.
No takes yet. Share an insight, caveat, or question.
Gharibzahedi et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: